Benzinga | Feb 25, 2021 07:22AM EST

Intercept Pharmaceuticals Q4 EPS $(1.58) Misses $(1.47) Estimate, Sales $83.27M Miss $85.01M Estimate

Intercept Pharmaceuticals (NASDAQ:ICPT) reported quarterly losses of $(1.58) per share which missed the analyst consensus estimate of $(1.47) by 7.48 percent. This is a 47.16 percent increase over losses of $(2.99) per share from the same period last year. The company reported quarterly sales of $83.27 million which missed the analyst consensus estimate of $85.01 million by 2.05 percent. This is a 16.46 percent increase over sales of $71.50 million the same period last year.